首页> 外文期刊>Asian journal of surgery >Is liquid-based hyaluronic acid equivalent to sodium hyaluronate-based bioresorbable membrane to reduce small bowel obstruction in patients undergoing colorectal surgery
【24h】

Is liquid-based hyaluronic acid equivalent to sodium hyaluronate-based bioresorbable membrane to reduce small bowel obstruction in patients undergoing colorectal surgery

机译:液体透明质酸是否等同于透明质酸钠生物可吸收膜,可减少结直肠手术患者的小肠梗阻

获取原文
获取外文期刊封面目录资料

摘要

ObjectiveWe performed a prospective randomized study to assess whether the use of sodium hyaluronate-based bioresorbable membrane (Seprafilm?) and liquid-based hyaluronic acid and carboxymethyl cellulose solution (Guardix) to reduce postoperative small bowel small bowel obstruction in patients undergoing colorectal surgery. This study aimed to compare the incidence of postoperative bowel obstruction.MethodsOne hundred seven patients were assigned to the Seprafilm?group and 155 were assigned to the Guardix?group during the study period. The control group of 166 patients received no anti-adhesive. Patients were randomly assigned.ResultsThe overall small bowel obstruction rate was 7.6% (N?=?37/488 patients). Small bowel obstruction developed in 9 patients (5.8%) in the Guardix?group and 9 patients (7.1%) in the Seprafilm?group and 19 patients (11.4%) in the control group. Seprafilm?group had significantly lower obstruction rate as compared to control group (P?=?0.036). Guardix?solution and Seprafilm?did not alter the liver and renal function, as assessed by the blood chemistry.ConclusionsThe use of Seprafilm significantly reduces the incidence of postoperative small bowel obstruction in patients undergoing colorectal surgery. We observed no difference in the incidence of postoperative small bowel obstruction after the application of Seprafilm?and Guardix?in patients undergoing colorectal surgery.
机译:目的我们进行了一项前瞻性随机研究,以评估是否使用透明质酸钠基生物可吸收膜(Seprafilm?)和液体基透明质酸和羧甲基纤维素溶液(Guardix)来减少结直肠手术患者术后小肠小肠梗阻。该方法旨在比较术后肠梗阻的发生率。方法在研究期间,将107例患者划入Seprafilm?组,将155例患者划入Guardix?组。对照组166名患者未接受抗粘连剂。结果患者的总体小肠梗阻率为7.6%(N≥37/ 488)。 Guardix®组有9例(5.8%)出现小肠梗阻,Seprafilm?组有9例(7.1%),对照组为19例(11.4%)。与对照组相比,Seprafilm?组的梗阻率明显降低(P≥0.036)。血液化学评估表明,Guardix®溶液和Seprafilm®不会改变肝和肾功能。结论Seprafilm的使用可显着降低结直肠手术患者术后小肠梗阻的发生率。我们观察到在进行结直肠手术的患者中应用Seprafilm®和Guardix®后,术后小肠梗阻的发生率没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号